BIRC5 overexpression was reported in breast cancer, lung adenocarcinoma, and neuroblastic malignance specimens (Hagenbuchner et al., 2016; Hamy et al., 2016; Cao et al., 2019). The gene discussed is BIRC5; the disease is breast carcinoma.